Friday 5 January 2018

Middle East: A flourishing Pharmaceutical market

Pharmaceutical market has been flourished in Middle east countries which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates by the tremendous economic and industrial developments. It comprises a dynamic life sciences and healthcare market, due to their growing and ageing populations and increasing total healthcare expenditures per capita.

UAE Pharma market is the most advanced markets in the Middle East, associated with a strong expenditure of highest per-capita medicine and fundamentals of healthcare in the Middle East. The Dubai Health Authority has been working on developing the medical tourism sector. It aims in attracting the 1.3 million medical tourists annually by 2021. Over the next five years revenue generated by medical tourism is expected to grow by 13% annually.


As per studies it has been revealed that Dubai has made strong development in pharmaceutical trading. In 2010 exports of pharmaceutical products have accelerated from Dhs800m to Dhs3bn, while Imports too have risen from Dhs100m to Dhs400m in 2003. Thereby finalizing the status, Industry experts say that there is potential for exponential growth in the pharmaceutical products sector.

“18th International Conference on Medicinal and Pharmaceutical Chemistry” during October 18-19, 2018 at Dubai, UAE. This event would provide great opportunity in Discovering the world of Medicinal Chemistry, learning in a New Space, Meeting Experts and Finding New Tips & Tactics in the field of Pharmaceutical Science.
This event would provide the premier interdisciplinary forum for Researchers, Presenters, Exhibitors, Practitioners and Educators to discuss trends in technologies, developments and innovations in the field of Pharmaceutical Science. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Drug Discovery and Designing, Chemistry and Scientists of Relevant Field.

No comments:

Post a Comment